OptimizeRx (OPRX) Return on Invested Capital (2024 - 2026)

OptimizeRx (OPRX) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital rose 2.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 2.0% YoY), and the FY2025 full-year result was 0.03%, up 10.0% from the prior year.
• Return on Invested Capital rose to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2026 to a low of 0.03% in Q3 2024.
• A 3-year average of 0.01% and a median of 0.0% in 2025 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 3 bps in 2025, while the deepest fall reached 2 bps in 2025.
• Tracing OPRX's Return on Invested Capital over 3 years: stood at 0.01% in 2024, then surged by 150 bps to 0.01% in 2025, then rose by 13 bps to 0.01% in 2026.
• Business Quant data shows OPRX's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.